158 results
DEFR14A
VERU
Veru Inc
9 May 24
Revised proxy
1:02pm
safety monitoring boards, including Bristol-Myers Squibb, Sanofi, Astellas, Schering Plough, Auguron, AKZO, Dupont, Rhone-Poulenc Rorer, Aventis, Jansen
8-K
EX-99.1
VERU
Veru Inc
8 May 24
Veru Reports Fiscal 2024 Second Quarter Financial Results and Progress of its Enobosarm High Quality Weight Loss Clinical Program
7:00am
, double-blind, placebo-controlled, randomized, dose-finding clinical trial was designed to evaluate the safety and efficacy of enobosarm 3mg, enobosarm 6mg … .
Importantly, enobosarm has a large safety database, which includes 27 clinical trials involving 1581 men and women, some of which included patients
DEFA14A
VERU
Veru Inc
1 Apr 24
Additional proxy soliciting materials
4:31pm
with improvements in physical function as well as significant reductions in fat mass.
Enobosarm has a large safety database, which includes 27 clinical trials … involving 1581 men and women dosed with duration of treatment in some patients for up to 3 years. In this large safety database, enobosarm
DEFA14A
hesr4aaklsdgf4xo
22 Mar 24
Additional proxy soliciting materials
4:51pm
8-K
EX-99.1
cbj zgadgbozr7fv
8 Feb 24
Veru Reports Fiscal 2024 First Quarter Financial Highlights
7:00am
8-K
EX-99.2
lw1r kj0nys
18 Dec 23
Veru Announces Proposed Public Offering of Common Stock
9:01am
8-K
EX-1.1
zrdgvoueannua
18 Dec 23
Veru Announces Proposed Public Offering of Common Stock
9:01am
8-K
EX-99.1
3i4 lcul502t8e
18 Dec 23
Veru Announces Proposed Public Offering of Common Stock
9:01am
424B5
ni1 hg6rajg4z
15 Dec 23
Prospectus supplement for primary offering
4:04pm
424B5
61zqs3i7dw0ep6wb5
13 Dec 23
Prospectus supplement for primary offering
4:23pm
8-K
EX-99.1
4selm enp3k23mecj
13 Dec 23
Entry into a Material Definitive Agreement
4:04pm
8-K
1q72tyb0 qb4qjyi
13 Dec 23
Entry into a Material Definitive Agreement
4:04pm
8-K
wg5 ba7m0d
11 Sep 23
Other Events
7:00am